Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising results. However, the cost of this innovative drug and its supply have become key concerns for patients and healthcare practitioners. While tirzepatide has been authorized by regulatory agencies, its high-priced nature presents a significant challenge to